Errors exist on this page. Correct the errors and resubmit the form.

    National Vision Holdings, Inc. Reports Second Quarter 2021 Financial Results; Raises Fiscal 2021 Outlook

    View PDF

    Quarterly highlights compared to second quarter 2019:

    • Net revenue increased 28.0% to $549.5 million
    • Comparable store sales growth of 22.5%; Adjusted Comparable Store Sales Growth of 23.5%
    • Net income increased 267% to $37.6 million; Diluted EPS increased 230% to $0.42
    • Adjusted Operating Income increased 125% to $65.6 million
    • Adjusted Diluted EPS increased 163% to $0.48

     

    Duluth, Ga. -- August 12, 2021 -- National Vision Holdings, Inc. (NASDAQ: EYE) (“National Vision” or the “Company”) today reported its financial results for the second quarter ended July 3, 2021.

    Given the lack of comparability to the second quarter of fiscal 2020 when the Company temporarily closed all of its retail locations to the public through early June due to COVID-19, this release includes a comparison of fiscal 2021 results to fiscal 2019 pre-COVID results, in addition to a condensed comparison to fiscal 2020. For a complete discussion of fiscal 2021 results as compared to fiscal 2020, please see our Quarterly Report on Form 10-Q for the quarter ended July 3, 2021 filed with the Securities and Exchange Commission.

    “The National Vision team delivered exceptionally strong results for the second quarter,” stated Reade Fahs, chief executive officer. “We believe our continued operating momentum further demonstrates the benefit from the hastening of industry trends that favor our low price model and strong store-level execution to meet heightened demand for affordable eyewear and eye care. I would like to thank the 2,000-plus optometrists and over 13,000 associates at National Vision for their continued resilience and commitment to serve our patients and customers.”

    Mr. Fahs continued, “During the quarter, we opened 20 stores and achieved another major milestone, as our trailing twelve month net revenue surpassed $2 billion. Also, we were pleased by the positive trend in customer transactions throughout the quarter, especially in June when we lapped record re-opening results last year. Looking ahead, we continue to be excited about our long-term opportunities for expansion and market share growth. Given our consistent performance since re-opening last year and our safety first approach, we are confident in our ability to navigate the challenging and dynamic environment and remain in a position of strength to drive long-term value for our stakeholders.”

    Adjusted Comparable Store Sales Growth, Adjusted Operating Income, Adjusted EBITDA, Adjusted Diluted EPS, Adjusted Operating Margin, Adjusted EBITDA Margin, and EBITDA are not measures recognized under generally accepted accounting principles (“GAAP”). Please see “Non-GAAP Financial Measures” and “Reconciliation of Non-GAAP to GAAP Financial Measures” below for more information.

    Second Quarter 2021 Summary compared to Second Quarter 2019

    • Net revenue increased 28.0% to $549.5 million compared to the second quarter of 2019.
    • The impact from the timing of unearned revenue on net revenue and profitability was immaterial.
    • Comparable store sales growth was 22.5% and Adjusted Comparable Store Sales Growth was 23.5%.
    • During the second quarter of 2021, the Company opened 20 new stores, closed one store, and ended the quarter with 1,249 stores. Overall, store count grew 10.7% from June 29, 2019 to July 3, 2021.
    • Costs applicable to revenue increased 16.5% to $235.9 million compared to the second quarter of 2019. As a percentage of net revenue, costs applicable to revenue decreased 430 basis points to 42.9% compared to the second quarter of 2019. This decrease as a percentage of net revenue was primarily driven by lower growth in optometrist costs, increased eyeglass mix and higher eyeglass margin.
    • SG&A increased 28.5% to $234.2 million compared to the second quarter of 2019. As a percentage of net revenue, SG&A increased 20 basis points to 42.6% compared to the second quarter of 2019. This increase as a percentage of net revenue was primarily driven by higher stock compensation expense, higher performance-based incentive compensation and higher advertising investment, partially offset by leverage of corporate overhead and occupancy expenses.
    • Net income increased 267% to $37.6 million compared to the second quarter of 2019.
    • Diluted earnings per share increased 230% to $0.42 compared to the second quarter of 2019. Adjusted Diluted EPS increased 163% to $0.48 compared to the second quarter of 2019.
    • Adjusted Operating Income increased 125% to $65.6 million compared to the second quarter of 2019. Adjusted Operating Margin increased 510 basis points to 11.9% compared to the second quarter of 2019.

    Second Quarter 2021 Summary compared to Second Quarter 2020 (condensed)

    • Net revenue increased 111% to $549.5 million compared to the second quarter of 2020.
    • Net revenue was positively impacted by 16.5% due to the timing of unearned revenue.
    • Comparable store sales growth was 99.1% and Adjusted Comparable Store Sales Growth was 76.7%.
    • The Company opened 20 new stores, closed one store, and ended the quarter with 1,249 stores. Overall, store count grew 5.5% from June 27, 2020 to July 3, 2021.
    • Net income increased 186% to $37.6 million compared to the second quarter of 2020.
    • Diluted earnings (loss) per share increased 176% to $0.42 compared to the second quarter of 2020. Adjusted Diluted EPS (loss) increased 217% to $0.48 compared to the second quarter of 2020. The net change in margin on unearned revenue positively impacted Adjusted Diluted EPS by $0.29.
    • Adjusted Operating Income increased 290% to $65.6 million compared to the second quarter of 2020. Adjusted Operating Margin increased 2,510 basis points to 11.9% compared to the second quarter of 2020. The net change in margin on unearned revenue positively impacted Adjusted Operating Income by $32.5 million.

    Six-Month Period 2021 Summary compared to Six-Month Period 2019

    • Net revenue increased 21.7% to $1.1 billion compared to the same period of 2019.
    • Net revenue was negatively impacted by 0.8% due to the timing of unearned revenue.
    • Comparable store sales growth was 15.5% and Adjusted Comparable Store Sales Growth was 16.7%.
    • The Company opened 45 new stores, closed one store, and ended the period with 1,249 stores.
    • Costs applicable to revenue increased 11.1% to $460.6 million compared to the same period of 2019. As a percentage of net revenue, costs applicable to revenue decreased 400 basis points to 42.5% compared to the same period of 2019. This decrease as a percentage of net revenue was primarily driven by higher eyeglass margin, a higher mix of exam sales, and a lower growth in optometrist costs.
    • SG&A increased 21.7% to $457.8 million compared to the same period of 2019. As a percentage of net revenue, SG&A was unchanged at 42.2% compared to the same period of 2019. As a percentage of net revenue, the leverage of corporate overhead, occupancy and advertising expenses was offset by higher performance-based incentive compensation and higher stock compensation expense.
    • Net income increased 193% to $81.0 million compared to the same period of 2019.
    • Diluted earnings per share increased 163% to $0.89 compared to the same period of 2019. Adjusted Diluted EPS increased3% to $0.97 compared to the same period of 2019. The net change in margin on unearned revenue negatively impacted Adjusted Diluted EPS by $0.04.
    • Adjusted Operating Income increased 85.7% to $133.2 million compared to the same period of 2019. Adjusted Operating Margin increased 420 basis points to 12.3% compared to the same period of 2019. The net change in margin on unearned revenue negatively impacted Adjusted Operating Income by $5.8 million.

    Six-Month Period 2021 Summary compared to Six-Month Period 2020 (condensed)

    • Net revenue increased 48.5% to $1.1 billion compared to the same period of 2020.
    • Net revenue was positively impacted by 1.1% due to the timing of unearned revenue.
    • Comparable store sales growth was 48.9% and Adjusted Comparable Store Sales Growth was 53.3%.
    • Net income increased 338% to $81.0 million compared to the same period of 2020.
    • Diluted earnings (loss) per share increased 310% to $0.89 compared to the same period of 2020. Adjusted Diluted EPS (loss) increased 855% to $0.97 compared to the same period of 2020. The net change in margin on unearned revenue positively impacted Adjusted Diluted EPS by $0.07.
    • Adjusted Operating Income increased to $133.2 million compared to the same period of 2020. Adjusted Operating Margin increased 1,180 basis points to 12.3% compared to the same period of 2020. The net change in margin on unearned revenue positively impacted Adjusted Operating Income by $6.1 million.

     

     

    Balance Sheet and Cash Flow Highlights as of July 3, 2021

    • The Company’s cash balance was $408.3 million as of July 3, 2021. The Company had no borrowings under its $300.0 million first lien revolving credit facility, exclusive of letters of credit of $6.4 million.
    • Total debt was $620.4 million as of July 3, 2021, consisting of outstanding first lien term loans, convertible senior notes and finance lease obligations, net of unamortized discounts.
    • In June 2021, the Company voluntarily prepaid $117.4 million in existing Term A loans. In addition, the Company amended its credit agreement to reduce the applicable margin for interest rate calculations and modify certain financial covenants back to pre-COVID terms.
    • Cash flows from operating activities for the first six-months of 2021 were $189.8 million compared to $71.4 million for the same period of 2020 and $119.3 million for the same period of 2019.
    • Capital expenditures for the first six-months of 2021 totaled $38.8 million compared to $25.8 million for the same period of 2020 and $52.1 million for the same period of 2019.

     

    Fiscal 2021 Outlook

    The Company’s updated fiscal 2021 outlook reflects the currently expected impacts related to COVID-19, however, the ultimate impacts of COVID-19 on the Company’s financial outlook remain uncertain. The outlook shown below assumes no material deterioration to the Company’s current business operations as a result of COVID-19 and its variants, governmental actions and regulations. Given the uncertainties, dynamic nature, variants, and unknown duration of the pandemic, the Company is continuing to evaluate additional measures that may be taken to respond to the impact of COVID-19 on its business.

    The Company is providing the following updated outlook for the 52 weeks ending January 1, 2022:

     

    Updated Fiscal 2021 Outlook

    Prior Fiscal 2021 Outlook

    New Stores

    ~75

    ~75

    Adjusted Comparable Store Sales Growth1

    19% - 22%

    16% - 19%

    Net Revenue

    $2.01 - $2.06 billion

    $1.975 - $2.025 billion

    Adjusted Operating Income

    $180 - $187 million

    $155 - $162 million

    Adjusted Diluted EPS2

    $1.28 - $1.33

    $1.07 - $1.12

    Depreciation and Amortization3

    ~$98 million

    $97 - $98 million

    Interest4

    ~$25 million

    ~$28 million

    Tax Rate5

    ~26%

    ~26%

    Capital Expenditures

    $100 - $105 million

    $100 - $105 million

     

     

     

    1 - For the 52 weeks ending January 1, 2022 compared to the 52 weeks ended January 2, 2021

    2 - Assumes 96.3 million shares, including 12.9 million shares for the convertible notes calculated using the if-converted method

    3 - Includes amortization of acquisition intangibles of approximately $7.5 million for the 52 weeks ending January 1, 2022

    4 - Before the impact of gains or losses related to hedge ineffectiveness and charges related to amortization of debt discounts and deferred financing costs

    5 - Excluding the impact of stock option exercises

     

    The fiscal 2021 outlook information provided above includes Adjusted Operating Income and Adjusted Diluted EPS guidance, which are non-GAAP financial measures management uses in measuring performance. The Company is not able to reconcile these forward-looking non-GAAP measures to GAAP without unreasonable efforts because it is not possible to predict with a reasonable degree of certainty the actual impact of certain items and unanticipated events, including taxes and non-recurring items, which would be included in GAAP results. The impact of such items and unanticipated events could be potentially significant.

    The fiscal 2021 outlook is forward-looking, subject to significant business, economic, regulatory and competitive uncertainties and contingencies, many of which are beyond the control of the Company and its management, and based upon assumptions with respect to future decisions, which are subject to change. Actual results may vary and those variations may be material. As such, the Company’s results may not fall within the ranges contained in its fiscal 2021 outlook. The Company uses these forward looking measures internally to assess and benchmark its results and strategic plans.

    Conference Call Details

    A conference call to discuss the second quarter 2021 financial results is scheduled for today, August 12, 2021, at 10:00 a.m. Eastern Time. The U.S. toll free dial-in for the conference call is 866-754-6931 and the international dial-in is 636-812-6625. The conference passcode is 5298057. A live audio webcast of the conference call will be available on the “Investors” section of the Company’s website www.nationalvision.com/investors, where presentation materials will be posted prior to the conference call.

    A telephone replay will be available shortly after the broadcast through Thursday, August 19, 2021, by dialing 855-859-2056 from the U.S. or 404-537-3406 from international locations, and entering conference passcode 5298057. A replay of the audio webcast will also be archived on the “Investors” section of the Company’s website.

     

    About National Vision Holdings, Inc.

    National Vision Holdings, Inc. is the second largest optical retail company in the United States (by sales) with more than 1,200 retail stores in 44 states plus the District of Columbia and Puerto Rico. With a mission of helping people by making quality eye care and eyewear more affordable and accessible, the Company operates five retail brands: America’s Best Contacts & Eyeglasses, Eyeglass World, Vision Centers inside select Walmart stores, and Vista Opticals inside select Fred Meyer stores and on select military bases, and several e-commerce websites, offering a variety of products and services for customers’ eye care needs.

    Forward-Looking Statements

    This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”) and Section 21E of the Securities Exchange Act of 1934. These statements include, but are not limited to, statements contained under “Fiscal 2021 Outlook” as well as other statements related to our current beliefs and expectations regarding the performance of our industry, the Company’s strategic direction, market position, prospects and future results. You can identify these forward-looking statements by the use of words such as “outlook,” “guidance,” “believes,” “expects,” “potential,” “continues,” “may,” “will,” “should,” “could,” “seeks,” “projects,” “predicts,” “intends,” “plans,” “estimates,” “anticipates” or the negative version of these words or other comparable words. Caution should be taken not to place undue reliance on any forward-looking statement as such statements speak only as of the date when made. We undertake no obligation to publicly update or review any forward-looking statement, whether as a result of new information, future developments or otherwise, except as required by law. Forward-looking statements are not guarantees and are subject to various risks and uncertainties, which may cause actual results to differ materially from those implied in forward-looking statements. Such factors include, but are not limited to, the COVID-19 pandemic and its resurgence and variants, and the impact of evolving federal, state, and local governmental actions in response thereto; customer behavior in response to the continuing pandemic and its more recent outbreaks of variants; our ability to keep our reopened stores open in a safe and cost-effective manner, or at all, in light of the continuing COVID-19 pandemic and its resurgence and variants; our ability to recruit and retain vision care professionals for our stores in general and in light of the pandemic; our ability to develop, maintain and extend relationships with managed vision care companies, vision insurance providers and other third-party payors; our ability to maintain the performance of our host and legacy brands and our current operating relationships with our host and legacy partners; our ability to adhere to extensive state, local and federal vision care and healthcare laws and regulations; our compliance with managed vision care laws and regulations; our ability to maintain sufficient levels of cash flow from our operations to execute or sustain our growth strategy or obtain additional financing at satisfactory terms or at all; the loss of, or disruption in the operations of, one or more of our distribution centers and/or optical laboratories, resulting in the inability to fulfill customer orders and deliver our products in a timely manner; risks associated with vendors from whom our products are sourced, including our dependence on a limited number of suppliers; our ability to compete successfully; our ability to effectively operate our information technology systems and prevent interruption or security breach; our growth strategy straining our existing resources and causing the performance of our existing stores to suffer; the impact of wage rate increases, inflation, cost increases and increases in raw material prices and energy prices; our ability to successfully implement our marketing, advertising and promotional efforts; risks associated with leasing substantial amounts of space, including future increases in occupancy costs; the impact of certain technological advances, and the greater availability of, or increased consumer preferences for, vision correction alternatives to prescription eyeglasses or contact lenses, and future drug development for the correction of vision-related problems; our ability to retain our existing senior management team and attract qualified new personnel; overall decline in the health of the economy and other factors impacting consumer spending; our ability to manage our inventory; seasonal fluctuations in our operating results and inventory levels; our reliance on third-party coverage and reimbursement, including government programs, for an increasing portion of our revenues; risks associated with our e-commerce and omni-channel business; product liability, product recall or personal injury issues; our failure to comply with, or changes in, laws, regulations, enforcement activities and other requirements; the impact of any adverse litigation judgments or settlements resulting from legal proceedings relating to our business operations; risk of losses arising from our investments in technological innovators in the optical retail industry; our ability to adequately protect our intellectual property; our significant amount of indebtedness and our ability to generate sufficient cash flow to satisfy our debt obligations; a change in interest rates as well as changes in benchmark rates and uncertainty related to the foregoing; restrictions in our credit agreement that limits our flexibility in operating our business; potential dilution to existing stockholders upon the conversion of our convertible notes; and risks related to owning our common stock, including our ability to comply with requirements to design and implement and maintain effective internal controls. Additional information about these and other factors that could cause National Vision’s results to differ materially from those described in the forward-looking statements can be found in filings by National Vision with the Securities and Exchange Commission (“SEC”), including our latest Annual Report on Form 10-K and subsequently filed reports, which are accessible on the SEC’s website at www.sec.gov. These factors should not be construed as exhaustive and should be read in conjunction with the other cautionary statements that are included in this release and in our filings with the SEC.

    Non-GAAP Financial Measures

    To supplement the Company’s financial information presented in accordance with GAAP and aid understanding of the Company’s business performance, the Company uses certain non-GAAP financial measures, namely “EBITDA,” “Adjusted Operating Income,” “Adjusted Operating Margin,” “Adjusted EBITDA,” “Adjusted EBITDA Margin,” “Adjusted Diluted EPS,” “Adjusted Comparable Stores Sales Growth,” “Adjusted SG&A,” and “Adjusted SG&A Percent of Net Revenue.” We believe EBITDA, Adjusted Operating Income, Adjusted Operating Margin, Adjusted EBITDA, Adjusted EBITDA Margin, Adjusted Diluted EPS, Adjusted SG&A and Adjusted SG&A Percent of Net Revenue assist investors and analysts in comparing our operating performance across reporting periods on a consistent basis by excluding items that we do not believe are indicative of our core operating performance. Management believes these non-GAAP financial measures are useful to investors in highlighting trends in our operating performance, while other measures can differ significantly depending on long-term strategic decisions regarding capital structure, the tax jurisdictions in which we operate and capital investments. Management uses these non-GAAP financial measures to supplement GAAP measures of performance in the evaluation of the effectiveness of our business strategies, to make budgeting decisions, to establish discretionary annual incentive compensation and to compare our performance against that of other peer companies using similar measures. Management supplements GAAP results with non-GAAP financial measures to provide a more complete understanding of the factors and trends affecting the business than GAAP results alone.

    To supplement the Company’s comparable store sales growth presented in accordance with GAAP, the Company provides “Adjusted Comparable Store Sales Growth,” which is a non-GAAP financial measure we believe is useful because it provides timely and accurate information relating to the two core metrics of retail sales: number of transactions and value of transactions. Management uses Adjusted Comparable Store Sales Growth as the basis for key operating decisions, such as allocation of advertising to particular markets and implementation of special marketing programs. Accordingly, we believe that Adjusted Comparable Store Sales Growth provides timely and accurate information relating to the operational health and overall performance of each brand. We also believe that, for the same reasons, investors find our calculation of Adjusted Comparable Store Sales Growth to be meaningful.

    EBITDA: We define EBITDA as net income (loss), plus interest expense, income tax provision (benefit) and depreciation and amortization.

    Adjusted Operating Income: We define Adjusted Operating Income as net income (loss), plus interest expense and income tax provision (benefit), further adjusted to exclude stock compensation expense, asset impairment, litigation settlement, management realignment expenses, long-term incentive plan expense, amortization of acquisition intangibles, and other expenses.

    Adjusted Operating Margin: We define Adjusted Operating Margin as Adjusted Operating Income as a percentage of net revenue.

    Adjusted EBITDA: We define Adjusted EBITDA as net income, plus interest expense, income tax provision (benefit) and depreciation and amortization, further adjusted to exclude stock compensation expense, asset impairment, litigation settlement, management realignment expenses, long-term incentive plan expense, and other expenses.

    Adjusted EBITDA Margin: We define Adjusted EBITDA Margin as Adjusted EBITDA as a percentage of net revenue.

    Adjusted Diluted EPS: We define Adjusted Diluted EPS as diluted earnings (loss) per share, adjusted for the per share impact of stock compensation expense, asset impairment, litigation settlement, management realignment expenses, long-term incentive plan expense, amortization of acquisition intangibles, amortization of debt discount and deferred financing costs of our term loan borrowings, amortization of costs related to our 2025 Notes, losses (gains) on change in fair value of derivatives, other expenses, and tax benefit of stock option exercises, less the tax effect of these adjustments. We adjust for amortization of costs related to the 2025 Notes only when adjustment for these costs is not required in the calculation of diluted earnings per share according to U.S. GAAP.

    Adjusted SG&A: We define Adjusted SG&A as SG&A, adjusted to exclude stock compensation expense, management realignment expenses, long-term incentive plan expense, and other expenses.

    Adjusted SG&A Percent of Net Revenue: We define Adjusted SG&A Percent of Net Revenue as Adjusted SG&A as a percentage of net revenue.

    Adjusted Comparable Store Sales Growth: We measure Adjusted Comparable Store Sales Growth as the increase or decrease in sales recorded by the comparable store base in any reporting period, compared to sales recorded by the comparable store base in the prior reporting period, which we calculate as follows: (i) sales are recorded on a cash basis (i.e., when the order is placed and paid for or submitted to a managed care payor, compared to when the order is delivered), utilizing cash basis point of sale information from stores; (ii) stores are added to the calculation during the 13th full fiscal month following the store’s opening; (iii) closed stores are removed from the calculation for time periods that are not comparable;  (iv) sales from partial months of operation are excluded when stores do not open or close on the first day of the month; and (v) when applicable, we adjust for the effect of the 53rd week. Quarterly, year-to-date and annual adjusted comparable store sales are aggregated using only sales from all whole months of operation included in both the current reporting period and the prior reporting period. When a partial month is excluded from the calculation, the corresponding month in the subsequent period is also excluded from the calculation. There may be variations in the way in which some of our competitors and other retailers calculate comparable store sales. As a result, our adjusted comparable store sales may not be comparable to similar data made available by other retailers. We did not adjust our calculation of Adjusted Comparable Store Sales Growth for the temporary closure of our stores to the public in 2020 as a result of the COVID-19 pandemic.

    EBITDA, Adjusted Operating Income, Adjusted Operating Margin, Adjusted EBITDA, Adjusted EBITDA Margin, Adjusted Diluted EPS, Adjusted SG&A, Adjusted SG&A Percent of Net Revenue, and Adjusted Comparable Store Sales Growth are not recognized terms under GAAP and should not be considered as an alternative to net income or the ratio of net income to net revenue as a measure of financial performance, SG&A, the ratio of SG&A to net revenue as a measure of financial performance, cash flows provided by operating activities as a measure of liquidity, comparable store sales growth as a measure of operating performance, or any other performance measure derived in accordance with GAAP. Additionally, these measures are not intended to be a measure of free cash flow available for management’s discretionary use as they do not consider certain cash requirements such as interest payments, tax payments and debt service requirements. The presentations of these measures have limitations as analytical tools and should not be considered in isolation, or as a substitute for analysis of our results as reported under GAAP. Because not all companies use identical calculations, the presentations of these measures may not be comparable to other similarly titled measures of other companies and can differ significantly from company to company.

    Please see “Reconciliation of Non-GAAP to GAAP Financial Measures” below for reconciliations of non-GAAP financial measures used in this release to their most directly comparable GAAP financial measures.

     


    National Vision Holdings, Inc. and Subsidiaries

    Condensed Consolidated Balance Sheets

    As of July 3, 2021 and January 2, 2021

    In Thousands, Except Par Value

    (Unaudited)

    ASSETS

    As of
    July 3, 2021

     

    As of
    January 2, 2021

    Current assets:

     

     

     

    Cash and cash equivalents

    $

    408,301 

     

     

    $

    373,903 

     

    Accounts receivable, net

    54,733 

     

     

    57,989 

     

    Inventories

    120,863 

     

     

    111,274 

     

    Prepaid expenses and other current assets

    24,466 

     

     

    23,484 

     

    Total current assets

    608,363 

     

     

    566,650 

     

     

     

     

     

    Property and equipment, net

    335,504 

     

     

    341,293 

     

    Other assets:

     

     

     

    Goodwill

    777,613 

     

     

    777,613 

     

    Trademarks and trade names

    240,547 

     

     

    240,547 

     

    Other intangible assets, net

    45,766 

     

     

    49,511 

     

    Right of use assets

    343,708 

     

     

    340,141 

     

    Other assets

    17,715 

     

     

    17,743 

     

    Total non-current assets

    1,760,853 

     

     

    1,766,848 

     

    Total assets

    $

    2,369,216 

     

     

    $

    2,333,498 

     

    LIABILITIES AND STOCKHOLDERS’ EQUITY

     

     

     

    Current liabilities:

     

     

     

    Accounts payable

    $

    77,677 

     

     

    $

    64,861 

     

    Other payables and accrued expenses

    116,508 

     

     

    110,309 

     

    Unearned revenue

    39,071 

     

     

    32,657 

     

    Deferred revenue

    68,612 

     

     

    58,899 

     

    Current maturities of long-term debt and finance lease obligations

    4,285 

     

     

    3,598 

     

    Current operating lease obligations

    64,330 

     

     

    58,356 

     

    Total current liabilities

    370,483 

     

     

    328,680 

     

     

     

     

     

    Long-term debt and finance lease obligations, less current portion and debt discount

    616,160 

     

     

    651,763 

     

    Non-current operating lease obligations

    326,478 

     

     

    327,371 

     

    Other non-current liabilities:

     

     

     

    Deferred revenue

    23,483 

     

     

    20,828 

     

    Other liabilities

    14,272 

     

     

    17,415 

     

    Deferred income taxes, net

    80,003 

     

     

    80,939 

     

    Total other non-current liabilities

    117,758 

     

     

    119,182 

     

    Commitments and contingencies

     

     

     

    Stockholders’ equity:

     

     

     

    Common stock, $0.01 par value; 200,000 shares authorized; 82,828 and 82,183 shares issued as of July 3, 2021 and January 2, 2021, respectively; 81,855 and 81,239 shares outstanding as of July 3, 2021 and January 2, 2021, respectively

    828 

     

     

    821 

     

    Additional paid-in capital

    739,380 

     

     

    795,697 

     

    Accumulated other comprehensive loss

    (3,093)

     

     

    (4,400)

     

    Retained earnings

    231,184 

     

     

    142,880 

     

    Treasury stock, at cost; 973 and 944 shares as of July 3, 2021 and January 2, 2021, respectively

    (29,962)

     

     

    (28,496)

     

    Total stockholders’ equity

    938,337 

     

     

    906,502 

     

    Total liabilities and stockholders’ equity

    $

    2,369,216 

     

     

    $

    2,333,498 

     

    National Vision Holdings, Inc. and Subsidiaries

    Condensed Consolidated Statements of Operations and Comprehensive Income

    For the Three and Six Months Ended July 3, 2021, June 27, 2020 and June 29, 2019

    In Thousands, Except Earnings Per Share

    (Unaudited)

     

    Three Months Ended

     

    Six Months Ended

     

    July 3, 2021

     

    June 27, 2020

     

    June 29, 2019

     

    July 3, 2021

     

    June 27, 2020

     

    June 29, 2019

    Revenue:

     

     

     

     

     

     

     

     

     

     

     

    Net product sales

    $

    458,206 

     

     

    $

    209,707 

     

     

    $

    357,533 

     

     

    $

    901,273 

     

     

    $

    602,548 

     

     

    $

    740,693 

     

    Net sales of services and plans

    91,283 

     

     

    50,300 

     

     

    71,918 

     

     

    182,396 

     

     

    127,163 

     

     

    149,973 

     

    Total net revenue

    549,489 

     

     

    260,007 

     

     

    429,451 

     

     

    1,083,669 

     

     

    729,711 

     

     

    890,666 

     

    Costs applicable to revenue (exclusive of depreciation and amortization):

     

     

     

     

     

     

     

     

     

     

     

    Products

    167,028 

     

     

    97,635 

     

     

    145,654 

     

     

    326,719 

     

     

    254,005 

     

     

    299,658 

     

    Services and plans

    68,918 

     

     

    43,145 

     

     

    56,852 

     

     

    133,917 

     

     

    105,329 

     

     

    114,817 

     

    Total costs applicable to revenue

    235,946 

     

     

    140,780 

     

     

    202,506 

     

     

    460,636 

     

     

    359,334 

     

     

    414,475 

     

    Operating expenses:

     

     

     

     

     

     

     

     

     

     

     

    Selling, general and administrative expenses

    234,235 

     

     

    136,582 

     

     

    182,278 

     

     

    457,828 

     

     

    330,323 

     

     

    376,154 

     

    Depreciation and amortization

    24,025 

     

     

    21,924 

     

     

    20,819 

     

     

    47,580 

     

     

    46,734 

     

     

    41,234 

     

    Asset impairment

    519 

     

     

    2,411 

     

     

    1,790 

     

     

    1,478 

     

     

    13,766 

     

     

    3,872 

     

    Litigation settlement

    — 

     

     

    — 

     

     

    — 

     

     

    — 

     

     

    4,395 

     

     

    — 

     

    Other expense (income), net

    (65)

     

     

    (92)

     

     

    356 

     

     

    (130)

     

     

    (158)

     

     

    829 

     

    Total operating expenses

    258,714 

     

     

    160,825 

     

     

    205,243 

     

     

    506,756 

     

     

    395,060 

     

     

    422,089 

     

    Income (loss) from operations

    54,829 

     

     

    (41,598)

     

     

    21,702 

     

     

    116,277 

     

     

    (24,683)

     

     

    54,102 

     

    Interest expense, net

    10,096 

     

     

    15,502 

     

     

    8,968 

     

     

    16,426 

     

     

    22,957 

     

     

    18,029 

     

    Debt issuance costs

    92 

     

     

    136 

     

     

    — 

     

     

    92 

     

     

    136 

     

     

    — 

     

    Earnings (loss) before income taxes

    44,641 

     

     

    (57,236)

     

     

    12,734 

     

     

    99,759 

     

     

    (47,776)

     

     

    36,073 

     

    Income tax provision (benefit)

    7,040 

     

     

    (13,403)

     

     

    2,477 

     

     

    18,726 

     

     

    (13,685)

     

     

    8,387 

     

    Net income (loss)

    $

    37,601 

     

     

    $

    (43,833)

     

     

    $

    10,257 

     

     

    $

    81,033 

     

     

    $

    (34,091)

     

     

    $

    27,686 

     

     

     

     

     

     

     

     

     

     

     

     

     

    Earnings (loss) per share:

     

     

     

     

     

     

     

     

     

     

     

    Basic

    $

    0.46 

     

     

    $

    (0.55)

     

     

    $

    0.13 

     

     

    $

    0.99 

     

     

    $

    (0.42)

     

     

    $

    0.35 

     

    Diluted

    $

    0.42 

     

     

    $

    (0.55)

     

     

    $

    0.13 

     

     

    $

    0.89 

     

     

    $

    (0.42)

     

     

    $

    0.34 

     

    Weighted average shares outstanding:

     

     

     

     

     

     

     

     

     

     

     

    Basic

    81,601 

     

     

    80,325 

     

     

    78,318 

     

     

    81,457 

     

     

    80,226 

     

     

    78,262 

     

    Diluted

    96,082 

     

     

    80,325 

     

     

    81,424 

     

     

    96,044 

     

     

    80,226 

     

     

    81,437 

     

     

     

     

     

     

     

     

     

     

     

     

     

    Comprehensive income (loss):

     

     

     

     

     

     

     

     

     

     

     

    Net income (loss)

    $

    37,601 

     

     

    $

    (43,833)

     

     

    $

    10,257 

     

     

    $

    81,033 

     

     

    $

    (34,091)

     

     

    $

    27,686 

     

    Unrealized gain (loss) on hedge instruments

    2,959 

     

     

    4,111 

     

     

    (2,246)

     

     

    4,609 

     

     

    (4,747)

     

     

    (3,519)

     

    Tax provision (benefit) of unrealized gain (loss) on hedge instruments

    756 

     

     

    1,050 

     

     

    (576)

     

     

    3,302 

     

     

    (1,206)

     

     

    (902)

     

    Comprehensive income (loss)

    $

    39,804 

     

     

    $

    (40,772)

     

     

    $

    8,587 

     

     

    $

    82,340 

     

     

    $

    (37,632)

     

     

    $

    25,069 

     

     

    Note: The three and six-months ended July 3, 2021 diluted EPS is calculated using the if-converted method for the 2025 Notes adding back $2.4 million and $4.7 million of interest expense (after tax) related to the 2025 Notes, respectively, and assuming conversion of the 2025 Notes at the beginning of 2021.

    National Vision Holdings, Inc. and Subsidiaries

    Condensed Consolidated Statements of Cash Flows

    For the Six Months Ended July 3, 2021, June 27, 2020 and June 29, 2019

    In Thousands

    (Unaudited)

     

    Six Months Ended

     

    July 3, 2021

     

    June 27, 2020

     

    June 29, 2019

    Cash flows from operating activities:

     

     

     

     

     

    Net income (loss)

    $

    81,033 

     

     

    $

    (34,091)

     

     

    $

    27,686 

     

    Adjustments to reconcile net income to net cash provided by operating activities:

     

     

     

     

     

    Depreciation and amortization

    47,580 

     

     

    46,734 

     

     

    41,234 

     

    Amortization of debt discount and deferred financing costs

    2,268 

     

     

    2,717 

     

     

    892 

     

    Asset impairment

    1,478 

     

     

    13,766 

     

     

    3,872 

     

    Deferred income tax expense (benefit)

    14,582 

     

     

    (13,686)

     

     

    8,239 

     

    Stock based compensation expense

    10,201 

     

     

    5,445 

     

     

    4,717 

     

    Losses (gains) on change in fair value of derivatives

    125 

     

     

    4,871 

     

     

    — 

     

    Inventory adjustments

    619 

     

     

    2,883 

     

     

    2,043 

     

    Other

    1,253 

     

     

    3,328 

     

     

    6,759 

     

    Changes in operating assets and liabilities:

     

     

     

     

     

    Accounts receivable

    2,393 

     

     

    (14,408)

     

     

    (8,662)

     

    Inventories

    (10,208)

     

     

    6,814 

     

     

    8,319 

     

    Operating lease right of use assets and lease liabilities

    149 

     

     

    1,174 

     

     

    1,948 

     

    Other assets

    (1,148)

     

     

    2,047 

     

     

    6,137 

     

    Accounts payable

    12,816 

     

     

    11,630 

     

     

    3,458 

     

    Deferred and unearned revenue

    18,782 

     

     

    8,025 

     

     

    5,006 

     

    Other liabilities

    7,885 

     

     

    24,171 

     

     

    7,631 

     

    Net cash provided by operating activities

    189,808 

     

     

    71,420 

     

     

    119,279 

     

    Cash flows from investing activities:

     

     

     

     

     

    Purchase of property and equipment

    (38,812)

     

     

    (25,796)

     

     

    (52,103)

     

    Other

    22 

     

     

    265 

     

     

    315 

     

    Net cash used for investing activities

    (38,790)

     

     

    (25,531)

     

     

    (51,788)

     

    Cash flows from financing activities:

     

     

     

     

     

    Borrowings on long-term debt, net of discounts

    — 

     

     

    548,769 

     

     

    — 

     

    Repayments on long-term debt

    (117,375)

     

     

    (369,269)

     

     

    (2,500)

     

    Proceeds from exercise of stock options

    5,738 

     

     

    5,998 

     

     

    2,066 

     

    Purchase of treasury stock

    (1,466)

     

     

    (74)

     

     

    — 

     

    Payments of debt issuance costs

    (900)

     

     

    (12,400)

     

     

    — 

     

    Payments on finance lease obligations

    (2,526)

     

     

    (1,587)

     

     

    (1,190)

     

    Net cash provided by (used for) financing activities

    (116,529)

     

     

    171,437 

     

     

    (1,624)

     

    Net change in cash, cash equivalents and restricted cash

    34,489 

     

     

    217,326 

     

     

    65,867 

     

    Cash, cash equivalents and restricted cash, beginning of year

    375,159 

     

     

    40,307 

     

     

    17,998 

     

    Cash, cash equivalents and restricted cash, end of period

    $

    409,648 

     

     

    $

    257,633 

     

     

    $

    83,865 

     

     

     

     

     

     

     

    Supplemental cash flow disclosure information:

     

     

     

     

     

    Cash paid for interest

    $

    14,640 

     

     

    $

    13,810 

     

     

    $

    17,438 

     

    Cash paid (received) for taxes

    $

    6,995 

     

     

    $

    (1,452)

     

     

    $

    513 

     

    Capital expenditures accrued at the end of the period

    $

    8,827 

     

     

    $

    11,265 

     

     

    $

    22,033 

     

     

     

    National Vision Holdings, Inc. and Subsidiaries

    Reconciliation of Non-GAAP to GAAP Financial Measures

    For the Three and Six Months Ended July 3, 2021, June 27, 2020 and June 29, 2019

    In Thousands, Except Per Share Information

    (Unaudited)

    Reconciliation of Adjusted Operating Income to Net Income

     

    Three Months Ended

     

    Six Months Ended

    In thousands

    July 3, 2021

     

    June 27, 2020

     

    June 29, 2019

     

    July 3, 2021

     

    June 27, 2020

     

    June 29, 2019

    Net income (loss)

    $

    37,601 

     

     

    $

    (43,833)

     

     

    $

    10,257 

     

     

    $

    81,033 

     

     

    $

    (34,091)

     

     

    $

    27,686 

     

    Interest expense

    10,096 

     

     

    15,502 

     

     

    8,968 

     

     

    16,426 

     

     

    22,957 

     

     

    18,029 

     

    Income tax provision (benefit)

    7,040 

     

     

    (13,403)

     

     

    2,477 

     

     

    18,726 

     

     

    (13,685)

     

     

    8,387 

     

    Stock compensation expense (a)

    7,213 

     

     

    3,352 

     

     

    1,741 

     

     

    10,201 

     

     

    5,445 

     

     

    4,717 

     

    Asset impairment (b)

    519 

     

     

    2,411 

     

     

    1,790 

     

     

    1,478 

     

     

    13,766 

     

     

    3,872 

     

    Litigation settlement (c)

    — 

     

     

    — 

     

     

    — 

     

     

    — 

     

     

    4,395 

     

     

    — 

     

    Management realignment expenses (d)

    — 

     

     

    — 

     

     

    — 

     

     

    — 

     

     

    — 

     

     

    2,155 

     

    Long-term incentive plan (e)

    — 

     

     

    — 

     

     

    781 

     

     

    — 

     

     

    — 

     

     

    722 

     

    Amortization of acquisition intangibles (f)

    1,871 

     

     

    1,851 

     

     

    1,851 

     

     

    3,744 

     

     

    3,702 

     

     

    3,702 

     

    Other (i)

    1,241 

     

     

    (307)

     

     

    1,223 

     

     

    1,641 

     

     

    1,149 

     

     

    2,467 

     

    Adjusted Operating Income

    $

    65,581 

     

     

    $

    (34,427)

     

     

    $

    29,088 

     

     

    $

    133,249 

     

     

    $

    3,638 

     

     

    $

    71,737 

     

     

     

     

     

     

     

     

     

     

     

     

     

    Net income (loss) margin

    6.8 

    %

     

    (16.9)

    %

     

    2.4 

    %

     

    7.5 

    %

     

    (4.7)

    %

     

    3.1 

    %

    Adjusted Operating Margin

    11.9 

    %

     

    (13.2)

    %

     

    6.8 

    %

     

    12.3 

    %

     

    0.5 

    %

     

    8.1 

    %

     Note: Percentages reflect line item as a percentage of net revenue, adjusted for rounding

     

    Reconciliation of EBITDA and Adjusted EBITDA to Net Income

     

    Three Months Ended

     

    Six Months Ended

    In thousands

    July 3, 2021

     

    June 27, 2020

     

    June 29, 2019

     

    July 3, 2021

     

    June 27, 2020

     

    June 29, 2019

    Net income (loss)

    $

    37,601 

     

     

    $

    (43,833)

     

     

    $

    10,257 

     

     

    $

    81,033 

     

     

    $

    (34,091)

     

     

    $

    27,686 

     

    Interest expense

    10,096 

     

     

    15,502 

     

     

    8,968 

     

     

    16,426 

     

     

    22,957 

     

     

    18,029 

     

    Income tax provision (benefit)

    7,040 

     

     

    (13,403)

     

     

    2,477 

     

     

    18,726 

     

     

    (13,685)

     

     

    8,387 

     

    Depreciation and amortization

    24,025 

     

     

    21,924 

     

     

    20,819 

     

     

    47,580 

     

     

    46,734 

     

     

    41,234 

     

    EBITDA

    78,762 

     

     

    (19,810)

     

     

    42,521 

     

     

    163,765 

     

     

    21,915 

     

     

    95,336 

     

     

     

     

     

     

     

     

     

     

     

     

     

    Stock compensation expense (a)

    7,213 

     

     

    3,352 

     

     

    1,741 

     

     

    10,201 

     

     

    5,445 

     

     

    4,717 

     

    Asset impairment (b)

    519 

     

     

    2,411 

     

     

    1,790 

     

     

    1,478 

     

     

    13,766 

     

     

    3,872 

     

    Litigation settlement (c)

    — 

     

     

    — 

     

     

    — 

     

     

    — 

     

     

    4,395 

     

     

    — 

     

    Management realignment expenses (d)

    — 

     

     

    — 

     

     

    — 

     

     

    — 

     

     

    — 

     

     

    2,155 

     

    Long-term incentive plan (e)

    — 

     

     

    — 

     

     

    781 

     

     

    — 

     

     

    — 

     

     

    722 

     

    Other (i)

    1,241 

     

     

    (307)

     

     

    1,223 

     

     

    1,641 

     

     

    1,149 

     

     

    2,467 

     

    Adjusted EBITDA

    $

    87,735 

     

     

    $

    (14,354)

     

     

    $

    48,056 

     

     

    $

    177,085 

     

     

    $

    46,670 

     

     

    $

    109,269 

     

     

     

     

     

     

     

     

     

     

     

     

     

    Net income (loss) margin

    6.8 

    %

     

    (16.9)

    %

     

    2.4 

    %

     

    7.5 

    %

     

    (4.7)

    %

     

    3.1 

    %

    Adjusted EBITDA Margin

    16.0 

    %

     

    (5.5)

    %

     

    11.2 

    %

     

    16.3 

    %

     

    6.4 

    %

     

    12.3 

    %

    Note: Percentages reflect line item as a percentage of net revenue, adjusted for rounding

     

     

    Reconciliation of Adjusted Diluted EPS to Diluted EPS

     

    Three Months Ended

     

    Six Months Ended

    In thousands, except per share amounts

    July 3, 2021

     

    June 27, 2020

     

    June 29, 2019

     

    July 3, 2021

     

    June 27, 2020

     

    June 29, 2019

    Diluted EPS

    $

    0.42 

     

     

    $

    (0.55)

     

     

    $

    0.13 

     

     

    $

    0.89 

     

     

    $

    (0.42)

     

     

    $

    0.34 

     

    Stock compensation expense (a)

    0.08 

     

     

    0.04 

     

     

    0.02 

     

     

    0.11 

     

     

    0.07 

     

     

    0.06 

     

    Asset impairment (b)

    0.01 

     

     

    0.03 

     

     

    0.02 

     

     

    0.02 

     

     

    0.17 

     

     

    0.05 

     

    Litigation settlement (c)

    — 

     

     

    — 

     

     

    — 

     

     

    — 

     

     

    0.05 

     

     

    — 

     

    Management realignment expenses (d)

    — 

     

     

    — 

     

     

    — 

     

     

    — 

     

     

    — 

     

     

    0.03 

     

    Long-term incentive plan (e)

    — 

     

     

    — 

     

     

    0.01 

     

     

    — 

     

     

    — 

     

     

    0.01 

     

    Amortization of acquisition intangibles (f)

    0.02 

     

     

    0.02 

     

     

    0.02 

     

     

    0.04 

     

     

    0.05 

     

     

    0.05 

     

    Amortization of debt discount and deferred financing costs (g)

    0.01 

     

     

    0.03 

     

     

    0.01 

     

     

    0.01 

     

     

    0.03 

     

     

    0.01 

     

    Losses (gains) on change in fair value of derivatives (h)

    0.02 

     

     

    0.06 

     

     

    — 

     

     

    — 

     

     

    0.06 

     

     

    — 

     

    Other (m)

    0.01 

     

     

    — 

     

     

    0.02 

     

     

    (0.01)

     

     

    0.01 

     

     

    0.03 

     

    Tax benefit of stock option exercises (j)

    (0.04)

     

     

    — 

     

     

    (0.01)

     

     

    (0.05)

     

     

    (0.04)

     

     

    (0.02)

     

    Tax effect of total adjustments (k)

    (0.04)

     

     

    (0.05)

     

     

    (0.02)

     

     

    (0.05)

     

     

    (0.12)

     

     

    (0.06)

     

    Adjusted Diluted EPS

    $

    0.48 

     

     

    $

    (0.41)

     

     

    $

    0.18 

     

     

    $

    0.97 

     

     

    $

    (0.13)

     

     

    $

    0.49 

     

     

     

     

     

     

     

     

     

     

     

     

     

    Weighted average diluted shares outstanding

    96,082 

     

     

    80,325 

     

     

    81,424 

     

     

    96,044 

     

     

    80,226 

     

     

    81,437 

     

    Note: Some of the totals in the table above do not foot due to rounding differences

     

    Reconciliation of Adjusted SG&A and Adjusted SG&A Percent of Net Revenue to SG&A

     

    Three Months Ended

     

    Six Months Ended

    In thousands

    July 3, 2021

     

    June 27, 2020

     

    June 29, 2019

     

    July 3, 2021

     

    June 27, 2020

     

    June 29, 2019

    SG&A

    $

    234,235 

     

     

    $

    136,582 

     

     

    $

    182,278 

     

     

    $

    457,828 

     

     

    $

    330,323 

     

     

    $

    376,154 

     

    Stock compensation expense (a)

    7,213 

     

     

    3,352 

     

     

    1,741 

     

     

    10,201 

     

     

    5,445 

     

     

    4,717 

     

    Management realignment expenses (d)

    — 

     

     

    — 

     

     

    — 

     

     

    — 

     

     

    — 

     

     

    2,155 

     

    Long-term incentive plan (e)

    — 

     

     

    — 

     

     

    781 

     

     

    — 

     

     

    — 

     

     

    722 

     

    Other (l)

    1,241 

     

     

    (307)

     

     

    776 

     

     

    1,641 

     

     

    1,149 

     

     

    1,460 

     

    Adjusted SG&A

    $

    225,781 

     

     

    $

    133,537 

     

     

    $

    178,980 

     

     

    $

    445,986 

     

     

    $

    323,729 

     

     

    $

    367,100 

     

     

     

     

     

     

     

     

     

     

     

     

     

    SG&A Percent of Net Revenue

    42.6 

    %

     

    52.5 

    %

     

    42.4 

    %

     

    42.2 

    %

     

    45.3 

    %

     

    42.2 

    %

    Adjusted SG&A Percent of Net Revenue

    41.1 

    %

     

    51.4 

    %

     

    41.7 

    %

     

    41.2 

    %

     

    44.4 

    %

     

    41.2 

    %

    Note: Percentages reflect line item as a percentage of net revenue

     

    • Non-cash charges related to stock-based compensation programs, which vary from period to period depending on the timing of awards and performance vesting conditions.
    • Reflects write-off of property, equipment and lease related assets on closed or underperforming stores.
    • Expenses associated with settlement of litigation.
    • Expenses related to a non-recurring management realignment described in the Current Report on Form 8-K filed with the SEC on January 10, 2019.
    • Expenses pursuant to a long-term incentive plan for non-executive employees who were not participants in the management equity plan for fiscal year 2019. This plan was effective in 2014 following the acquisition of the Company by affiliates of KKR & Co. Inc. (the "KKR Acquisition").
    • Amortization of the increase in carrying values of finite-lived intangible assets resulting from the application of purchase accounting to the KKR Acquisition.
    • Amortization of deferred financing costs and other non-cash charges related to our long-term debt. We adjust for amortization of costs related to the 2025 Notes only when adjustment for these costs is not required in the calculation of diluted earnings per share according to U.S. GAAP. Amortization of debt discount and deferred financing costs in aggregate total $1.0 million, $2.5 million and $0.5 million for the three months ended July 3, 2021, June 27, 2020 and June 29, 2019, respectively, and $1.2 million, $2.7 million and $0.9 million for the six months ended July 3, 2021, June 27, 2020 and June 29, 2019, respectively.
    • Reflects losses (gains) recognized in interest expense on change in fair value of de-designated hedges of $2.4 million and $4.9 million for the three months ended July 3, 2021 and June 27, 2020, respectively, and $0.1 million and $4.9 million for the six months ended July 3, 2021 and June 27, 2020, respectively.
    • Other adjustments include amounts that management believes are not representative of our operating performance (amounts in brackets represent reductions in Adjusted Operating Income, Adjusted Diluted EPS and Adjusted EBITDA), including our share of losses on equity method investments of $0.4 million for the three months ended June 29, 2019 and $1.0 million for the six months ended June 29, 2019; the amortization impact of adjustments related to the KKR Acquisition, (e.g., fair value of leasehold interests) of $0.1 million for each of the three months ended July 3, 2021, June 27, 2020 and June 29, 2019, respectively, and $0.2 million for each of the six months ended July 3, 2021, June 27, 2020 and June 29, 2019, respectively; costs of severance and relocation of $0.7 million, $0.2 million and $0.6 million for the three months ended July 3, 2021, June 27, 2020 and June 29, 2019, respectively, and $0.8 million, $0.5 million and $0.8 million for the six months ended July 3, 2021, June 27, 2020 and June 29, 2019, respectively; excess payroll taxes related to stock option exercises of $0.2 million and $0.1 million for the three months ended July 3, 2021 and June 29, 2019, respectively, and $0.3 million, $0.3 million and $0.1 million for the six months ended July 3, 2021, June 27, 2020 and June 29, 2019, respectively; incremental costs directly related to adapting the Company’s operations during the COVID-19 pandemic of $0.6 million for the six months ended June 27, 2020; and other expenses and adjustments totaling $0.2 million and $(0.7) million for the three months ended July 3, 2021 and June 27, 2020, respectively, and $0.3 million, $(0.5) million and $0.3 million for the six months ended July 3, 2021, June 27, 2020 and June 29, 2019, respectively.
    • Tax benefit associated with accounting guidance requiring excess tax benefits related to stock option exercises to be recorded in earnings as discrete items in the reporting period in which they occur.
    • Represents the income tax effect of the total adjustments at our combined statutory federal and state income tax rates.
    • Reflects other expenses in (i) above, except for our share of losses on equity method investments of $0.4 million for the three months ended June 29, 2019 and $1.0 million for the six months ended June 29, 2019.
    • Reflects other expenses in (i) above, including the impact of stranded tax effect of $(2.1) million for the six months ended July 3, 2021 associated with our interest rate swaps that matured in 2021.

     

    Reconciliation of Adjusted Comparable Store Sales Growth to Total Comparable Store Sales Growth

     

    Comparable store sales growth(a)

     

    Second Quarter

     

    Year to Date

     

     

     

    2021 vs. 2019

     

    2021 vs. 2020

     

    2021 vs. 2019

     

    2021 vs. 2020

     

    2021 Outlook

    Owned & Host segment

     

     

     

     

     

     

     

     

     

    America’s Best

    26.1 

    %

     

    81.8 

    %

     

    18.4 

    %

     

    54.9 

    %

     

     

    Eyeglass World

    27.1 

    %

     

    67.6 

    %

     

    22.3 

    %

     

    57.1 

    %

     

     

    Military

    (0.2)

    %

     

    65.0 

    %

     

    (1.6)

    %

     

    38.1 

    %

     

     

    Fred Meyer

    (8.7)

    %

     

    61.1 

    %

     

    (10.3)

    %

     

    36.1 

    %

     

     

    Legacy segment

    11.4 

    %

     

    58.2 

    %

     

    6.1 

    %

     

    42.6 

    %

     

     

     

     

     

     

     

     

     

     

     

     

    Total comparable store sales growth

    22.5 

    %

     

    99.1 

    %

     

    15.5 

    %

     

    48.9 

    %

     

    18% - 21%

    Adjusted Comparable Store Sales Growth (b)

    23.5 

    %

     

    76.7 

    %

     

    16.7 

    %

     

    53.3 

    %

     

    19% - 22%

    • Total comparable store sales based on consolidated net revenue excluding the impact of (i) Corporate/Other segment net revenue, (ii) sales from stores opened less than 13 months, (iii) stores closed in the periods presented, (iv) sales from partial months of operation when stores do not open or close on the first day of the month and (v) if applicable, the impact of a 53rd week in a fiscal year. Brand-level comparable store sales growth is calculated based on cash basis revenues consistent with what the CODM reviews, and consistent with reportable segment revenues presented in Note 10. “Segment Reporting” in our unaudited condensed consolidated financial statements included in Part I. Item 1. in our Quarterly Report on Form 10-Q, with the exception of the Legacy segment, which is adjusted as noted in clause (b) (ii) below.
    • There are two differences between total comparable store sales growth based on consolidated net revenue and Adjusted Comparable Store Sales Growth: (i) Adjusted Comparable Store Sales Growth includes the effect of deferred and unearned revenue as if such revenues were earned at the point of sale, resulting in the following changes from total comparable store sales growth based on consolidated net revenue: an increase of 1.2% for second quarter 2021 vs. 2019, a decrease of 21.6% for second quarter 2021 vs. 2020, an increase of 1.2% for year to date 2021 vs. 2019 and an increase of 4.4% for year to date 2021 vs. 2020; and (ii) Adjusted Comparable Store Sales Growth includes retail sales to the Legacy partner’s customers (rather than the revenues recognized consistent with the management & services agreement with the Legacy partner), resulting in the following changes from total comparable store sales growth based on consolidated net revenue: a decrease of 0.2% for second quarter 2021 vs. 2019 and a decrease of 0.8% for second quarter 2021 vs. 2020.

     

     

     

     

     

     

    Investors:

     

    National Vision Holdings, Inc.

    David Mann, CFA, Vice President of Investor Relations

    (470) 448-2448

    [email protected]

     

    Media:

     

    National Vision Holdings, Inc.

    Racheal Peters, Manager of External Communications

    (470) 448-2303

    [email protected]

    Twitter

    Twitter

    Facebook

    Facebook

    LinkedIn

    LinkedIn

    YouTube

    YouTube

    Blog

    Blog